Please Wait.....
Report
Cognitive and Memory Enhancer Drugs Market Report by Product (Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and Others), Application (Disease Treatment, Athletic Performance, Academic Performance, and Others), and Region 2025-2033
Market Report I 2025-03-01 I 139 Pages I IMARC Group
The global cognitive and memory enhancer drugs market size reached USD 6,171.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 9,460.6 Million by 2033, exhibiting a growth rate (CAGR) of 4.86% during 2025-2033. The growing prevalence of cognitive disorders, increasing research and development (R&D) activities to explore new compounds and formulations, and introduction of novel drugs and innovative delivery methods represent some of the key factors driving the market.
Cognitive and memory enhancer drugs, also known as nootropics or smart drugs, aim to improve cognitive function like memory, attention, creativity, and overall mental performance. These drugs are designed to enhance brain activity and promote better cognitive abilities. They are available by prescription for specific medical conditions and can be purchased over the counter (OTC) or online as dietary supplements. They enhance alertness and focus by increasing the release of certain neurotransmitters in the brain. They also boost acetylcholine levels, which is important for memory and learning. They act as antioxidants or anti-inflammatory agents, protecting the brain from damage and promoting optimal brain function. They can also promote clearer thinking and improve cognitive processing speed and lead to better decision-making abilities. They assist in improving short-term and long-term memory, which makes it easier to recall and retain information. They also aid in enhancing academic or work performance by increasing productivity, efficiency, and cognitive abilities.
Cognitive and Memory Enhancer Drugs Market Trends:
At present, the rising prevalence of cognitive disorders, such as Alzheimer's disease, dementia, and attention deficit hyperactivity disorder (ADHD), represents one of the key factors supporting the growth of the market. Besides this, people are becoming more proactive in taking care of their brain health and seeking ways to enhance their cognitive abilities, which is catalyzing the demand for cognitive and memory enhancer drugs. Moreover, increasing research and development (R&D) activities to explore new compounds and formulations that can enhance cognitive functions and memory is propelling the growth of the market. In line with this, the development of novel drugs and innovative delivery methods is expanding the range of options available to consumers, which is strengthening the growth of the market. In addition, the growing demand for drugs that can alleviate age-related cognitive decline and memory loss due to the rising elderly population is offering a favorable market outlook. Apart from this, the increasing adoption of cognitive and memory enhancer drugs among students and professionals seeking improved academic and professional performance is creating lucrative growth opportunities for industry investors. Additionally, the wide availability of cognitive and memory enhancer drugs through online and offline distribution channels is strengthening the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global cognitive and memory enhancer drugs market, along with forecasts at the global, regional, and country levels from 2025-2033. Our report has categorized the market based on product and application.
Product Insights:
- Aricept
- Exelon
- Namenda
- Razadyne
- Provigil
- Ritalin
- Adderall
- Others
The report has provided a detailed breakup and analysis of the cognitive and memory enhancer drugs market based on the type. This includes Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and others. According to the report, Aricept represented the largest segment.
Application Insights:
- Disease Treatment
- Athletic Performance
- Academic Performance
- Others
A detailed breakup and analysis of the cognitive and memory enhancer drugs market based on the application has also been provided in the report. This includes disease treatment, athletic performance, academic performance, and others. According to the report, disease treatment accounted for the largest market share.
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cognitive and memory enhancer drugs. Some of the factors driving the North America cognitive and memory enhancer drugs market included the growing elderly population, increasing need to enhance focus, memory, and overall cognitive abilities, development of novel drugs, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global cognitive and memory enhancer drugs market. Detailed profiles of all major companies have been provided. Some of the companies covered include AbbVie Inc., Biogen Inc., Eisai Co Ltd., Novartis AG, Takeda Pharmaceutical Company Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global cognitive and memory enhancer drugs market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global cognitive and memory enhancer drugs market?
- What is the impact of each driver, restraint, and opportunity on the global cognitive and memory enhancer drugs market?
- What are the key regional markets?
- Which countries represent the most attractive cognitive and memory enhancer drugs market?
- What is the breakup of the market based on the product?
- Which is the most attractive product in the cognitive and memory enhancer drugs market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the cognitive and memory enhancer drugs market?
- What is the competitive structure of the global cognitive and memory enhancer drugs market?
- Who are the key players/companies in the global cognitive and memory enhancer drugs market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cognitive and Memory Enhancer Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Aricept
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Exelon
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Namenda
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Razadyne
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Provigil
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Ritalin
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Adderall
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast
7 Market Breakup by Application
7.1 Disease Treatment
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Athletic Performance
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Academic Performance
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 Drivers, Restraints, and Opportunities
9.1 Overview
9.2 Drivers
9.3 Restraints
9.4 Opportunities
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 AbbVie Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Biogen Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Eisai Co Ltd.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Novartis AG
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Takeda Pharmaceutical Company Ltd.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Figure 1: Global: Cognitive and Memory Enhancer Drugs Market: Major Drivers and Challenges
Figure 2: Global: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019-2024
Figure 3: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 4: Global: Cognitive and Memory Enhancer Drugs Market: Breakup by Product (in %), 2024
Figure 5: Global: Cognitive and Memory Enhancer Drugs Market: Breakup by Application (in %), 2024
Figure 6: Global: Cognitive and Memory Enhancer Drugs Market: Breakup by Region (in %), 2024
Figure 7: Global: Cognitive and Memory Enhancer Drugs (Aricept) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Cognitive and Memory Enhancer Drugs (Aricept) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Cognitive and Memory Enhancer Drugs (Exelon) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Cognitive and Memory Enhancer Drugs (Exelon) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Cognitive and Memory Enhancer Drugs (Namenda) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Cognitive and Memory Enhancer Drugs (Namenda) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Cognitive and Memory Enhancer Drugs (Razadyne) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Cognitive and Memory Enhancer Drugs (Razadyne) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Cognitive and Memory Enhancer Drugs (Provigil) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Cognitive and Memory Enhancer Drugs (Provigil) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Cognitive and Memory Enhancer Drugs (Ritalin) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Cognitive and Memory Enhancer Drugs (Ritalin) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Cognitive and Memory Enhancer Drugs (Adderall) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Cognitive and Memory Enhancer Drugs (Adderall) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Cognitive and Memory Enhancer Drugs (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Cognitive and Memory Enhancer Drugs (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Cognitive and Memory Enhancer Drugs (Disease Treatment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Cognitive and Memory Enhancer Drugs (Disease Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Cognitive and Memory Enhancer Drugs (Athletic Performance) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Cognitive and Memory Enhancer Drugs (Athletic Performance) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Cognitive and Memory Enhancer Drugs (Academic Performance) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Cognitive and Memory Enhancer Drugs (Academic Performance) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Cognitive and Memory Enhancer Drugs (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Cognitive and Memory Enhancer Drugs (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: North America: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: North America: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: United States: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: United States: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Canada: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Canada: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Asia-Pacific: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Asia-Pacific: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: China: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: China: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Japan: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Japan: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: India: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: India: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: South Korea: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: South Korea: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Australia: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Australia: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Indonesia: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Indonesia: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Others: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Others: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Europe: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Europe: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Germany: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Germany: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: France: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: France: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: United Kingdom: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: United Kingdom: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Italy: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Italy: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Spain: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Spain: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Russia: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Russia: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Others: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Others: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Latin America: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Latin America: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Brazil: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Brazil: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Mexico: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Mexico: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Others: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Others: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Middle East and Africa: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Middle East and Africa: Cognitive and Memory Enhancer Drugs Market: Breakup by Country (in %), 2024
Figure 79: Middle East and Africa: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Global: Cognitive and Memory Enhancer Drugs Industry: Drivers, Restraints, and Opportunities
Figure 81: Global: Cognitive and Memory Enhancer Drugs Industry: Value Chain Analysis
Figure 82: Global: Cognitive and Memory Enhancer Drugs Industry: Porter's Five Forces Analysis
Table 1: Global: Cognitive and Memory Enhancer Drugs Market: Key Industry Highlights, 2024 & 2033
Table 2: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Cognitive and Memory Enhancer Drugs Market: Competitive Structure
Table 6: Global: Cognitive and Memory Enhancer Drugs Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security